Griebling TL. Re: Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis. J Urol 2020 May 13:101097JU000000000000110204.
PMID: 32401576